Mobilization With Movement Versus Soft Tissue Mobilization in Patients With De Quervain Tenosynovitis

NCT ID: NCT05356624

Last Updated: 2022-05-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-15

Study Completion Date

2022-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study will investigate the effects of mobilization with movement in addition to soft tissue mobilization on pain and range of motion in patients suffering from De Quervain Tenosynovitis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

De quervain tenosynovitis also known as stenosing tenosynovitis is a condition which occur when tendons at the base of thumb pinched and become irritated. Several treatment options are available like ultrasound, Graston therapy, thrust or non-thrust manipulation, mobilization with movement, soft tissue mobilization but this study focus on 2 treatments to improve malalignment of the joint and also reduce pain. First treatment is mobilization with movement in which passive accessory mobilization from therapist while active mobility is performed by patient. Second technique is soft tissue mobilization in which passive glides are applied. The purpose of study is to make comparison between mobilization with movement and soft tissue mobilization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

De Quervain Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mulligan Mobilization

Mobilization with movement (3 sets per 10 repetitions).

Group Type EXPERIMENTAL

Mulligan Mobilization

Intervention Type OTHER

It is technique in which passive mobilization is applied by therapist to improve the normal position and by holding the passive glide active movement in restricted direction of motion to reduce pain or improve range of motion or function. A total of 3 sets of 10 repetition three times a week on alternate days for 6 week

Soft tissue mobilization

Soft tissue mobilization (3 sets per 10 repetitions)

Group Type EXPERIMENTAL

Soft Tissue Mobilization

Intervention Type OTHER

in this technique for joint the passive glides are applied, for CMC joint mobilization patient hand is rest on table. The therapist grasp trapezium with one hand and 1st metacarpal between index and thumb of other hand to apply glide. A total of 3 sets of 10 repetition three times a week on alternate days for 6 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mulligan Mobilization

It is technique in which passive mobilization is applied by therapist to improve the normal position and by holding the passive glide active movement in restricted direction of motion to reduce pain or improve range of motion or function. A total of 3 sets of 10 repetition three times a week on alternate days for 6 week

Intervention Type OTHER

Soft Tissue Mobilization

in this technique for joint the passive glides are applied, for CMC joint mobilization patient hand is rest on table. The therapist grasp trapezium with one hand and 1st metacarpal between index and thumb of other hand to apply glide. A total of 3 sets of 10 repetition three times a week on alternate days for 6 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female

* 20 to 50 years
* Subjects with pain in base of thumb (9)
* Subject with positive fienklstein test

Exclusion Criteria

* History of radiculopathy

* History of systemic illness
* History of connective tissue disorder
* Rheumatoid arthritis
* History of hand or wrist injury or acute trauma
* Subject with negative fienklstein test
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nosheen Manzoor, MS-OMPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aziz Bhatti Shaheed hospital

Gujrat, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nosheen Manzoor, MS-OMPT

Role: CONTACT

03236877879

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nosheen Manzoor

Role: primary

03236877879

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/Lhr/22/0108 Ayesha

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.